Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Maitland Noonan Russo was a specialized strategic communications and investor relations firm dedicated to the healthcare and life sciences sectors. Formed as a partnership between the UK-based financial PR agency Maitland and the US-based healthcare communications firm Noonan Russo, the entity served as a bridge for biotech and pharmaceutical companies seeking global reach in the late 1990s and early 2000s. The firm provided a range of services including media relations, financial advisory, and corporate positioning for emerging and established healthcare companies. Following the acquisition of Noonan Russo by Euro RSCG (Havas) and the eventual rebranding of the constituent firms, the partnership's functions were absorbed into larger global networks, with the US leadership later forming Russo Partners.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Maitland Noonan Russo.